| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/29/2010 | CN101130063B Segmented intestine targeted preparation of orgotein polypeptide and method of preparing the same |
| 12/29/2010 | CN101125198B Application of HSP27 in aspect for improving post-ischemic cardiac systolic function |
| 12/29/2010 | CN101054412B Pathogenic gene for far end arthrosis bend, detection method and application thereof |
| 12/29/2010 | CN101031647B Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli |
| 12/29/2010 | CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
| 12/29/2010 | CA2766322A1 Methods of using corticotropin-releasing factor for the treatment of cancer |
| 12/29/2010 | CA2766309A1 Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy |
| 12/29/2010 | CA2766157A1 Methods for diagnosing irritable bowel syndrome |
| 12/29/2010 | CA2765697A1 Diffusion enhancing compounds and their use alone or with thrombolytics |
| 12/29/2010 | CA2765108A1 Truncated actriib-fc fusion proteins |
| 12/29/2010 | CA2764779A1 Factor vii composition |
| 12/29/2010 | CA2764761A1 Methods for assessing tophus response during urate lowering therapy in treatment tophaceous gout |
| 12/29/2010 | CA2764758A1 Chimeric factor vii molecules |
| 12/29/2010 | CA2764423A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 12/29/2010 | CA2764131A1 Antimicrobial agents |
| 12/28/2010 | USRE42014 Pharmaceutical compositions |
| 12/28/2010 | USRE42013 Macrocyclic modulators of the ghrelin receptor |
| 12/28/2010 | USRE42012 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 12/28/2010 | US7858776 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein |
| 12/28/2010 | US7858771 Chemically modified short interfering nucleic acid molecule for use in treatment of respiratory and pulmonary disease |
| 12/28/2010 | US7858769 RNA interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional siNA) |
| 12/28/2010 | US7858765 OX40R binding agents |
| 12/28/2010 | US7858760 Antibodies to protein expressed in prostate cancer |
| 12/28/2010 | US7858754 Nel-related protein type 1 antibody |
| 12/28/2010 | US7858750 Antibodies to tumor associated proteins |
| 12/28/2010 | US7858748 for adjusting moisture content of precipitate, suspending in aqueous H2O2 solution, filtering, resuspending; for manufacture of products for medicinal purposes such as wound dressings |
| 12/28/2010 | US7858741 Stabilization of the collagen triple helix by O-methylation of hydroxyproline residues |
| 12/28/2010 | US7858740 A polypeptide useful in the treatment of Type I and II diabetes; delaying and/or slowing gastric emptying; lowering plasma glucose levels |
| 12/28/2010 | US7858739 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 12/28/2010 | US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 12/28/2010 | US7858679 Polymeric compositions and related methods of use |
| 12/28/2010 | US7858655 synergistic mixtures reduce damage to neurons after a neurodegenerative insult; time-release agents; antiischemic agents; amyotrophic lateral slerosis (ALS), Alzheimer's disease, Parkinson's disease, Hunntington's disease, multiple sclerosis |
| 12/28/2010 | US7858625 Conjugates and compositions for cellular delivery |
| 12/28/2010 | US7858591 Oligonucleotide sequences which bind biomolecules such as peptides; selectively bind coagulation factors, E2F family members, Ang1 or Ang2; hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals |
| 12/28/2010 | US7858586 Method of treating condition in animal |
| 12/28/2010 | US7858585 A polypeptide hydrogel containing VKVKVKVKVDPPTKVEVKVKV amino acid sequence, that may be formed by the self-assembly of peptides in solution and brought about by a change of the hydrogel e.g. pH, ionic strength, temperature, concentration of specific ions; drug delivery; wound healing; tissue engineering |
| 12/28/2010 | US7858584 Angiogenically effective unit dose of FGF and method of administering |
| 12/28/2010 | US7858583 a solution of the glycopeptide derivatives containing phosphono group which acts as antibacterial agent, a polystyrene modified with divinylbenzene bead and an acidified aqueous solution ( acetic acid or HCl) of polar solvent e.g. methanol, acetonitrile, ethanol; for purification by resin chromatography |
| 12/28/2010 | US7858582 external preparation containing recombinant human growth hormone or recombinant human granulocyte macrophage colony-stimulating factor and pharmaceutical acceptable carrier; corneal lesions and corneal ulcers |
| 12/28/2010 | US7858581 PMMA binding peptides and methods of use |
| 12/28/2010 | US7858580 Sequence of 4, 5 or 6 amino acids and derivative; dipeptide sequence Ile-Pro, Pro-Ile or combination; aging skin, atrophy, dryness, roughness, development of wrinkles, loss of elasticity, pigment irregularities |
| 12/28/2010 | US7858579 pkg inhibitor selected from KT5823; (Rp)-8-bromo-PET-cyclic GMPS (Guanosine 3',5'-cyclic Monophosphorothioate, ß-Phenyl-1,N 2 -etheno-8 -bromo-, Rp-Isomer); (Rp)-8-pCPT-cylic GMPS,TEA (Guanosine 3',5'-cyclic Monophosphorothioate, 8-(4 -Chlorophenylthio)-, Rp-Isomer, Triethylamine, fusion proteins |
| 12/28/2010 | US7858578 Methods of inducing neuronal growth by a Fucose-α(1-2) galactose (fuc-α(1-2) gal) moiety and a lectin |
| 12/28/2010 | US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2 |
| 12/28/2010 | US7858576 Method for targeting lysosomal enzymes |
| 12/28/2010 | US7858368 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 12/28/2010 | US7858367 includes a deleted adenovirus vector genome having the adenovirus 5' and 3' cis-elements for viral replication and encapsidation and a recombinant adeno-associated virus (AAV) vector genome flanked by the adenovirus vector genome sequences; for gene therapy |
| 12/28/2010 | US7858359 prokaryotic host cells comprising a library of at least 103 different RNA molecules each having a dicistronic coding region; for screening a larger portion of the immunological repertoire for receptors having a preselected activity |
| 12/28/2010 | US7858357 Immunization with bacterial ghost-based vaccines |
| 12/28/2010 | US7858349 Anti-cancer compounds |
| 12/28/2010 | US7858346 Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein |
| 12/28/2010 | US7858326 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function |
| 12/28/2010 | US7858322 Method of determining inhibition of binding to TRPM7 protein |
| 12/28/2010 | US7858297 Chemokine-binding protein and methods of use |
| 12/28/2010 | US7858295 Methods for prolonging survival of platelets using UDP-galactose |
| 12/28/2010 | US7858116 hepatocyte targeted composition comprising mixture of free recombinant human insulin isophane and free recombinant human regular insulin and mixture of recombinant human insulin isophane and recombinant human regular insulin associated with water insoluble target molecule complex; diabetes treatment |
| 12/28/2010 | US7858109 biodegradable filament having arranged thereon pressed form bodies consisting of at least one member of group of antibiotic salts such as gentamicin myristate, tobramycin palmitate; for treatment of chronic osteomyelitis |
| 12/28/2010 | US7858099 Method for inducing an immunological response in an animal |
| 12/28/2010 | US7858096 Mutant forms of meningococcal ADP-ribosylating toxin |
| 12/28/2010 | US7858095 Method for treating or preventing sclerotic disorders using CD-2 binding agents |
| 12/28/2010 | US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 12/28/2010 | US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 12/28/2010 | US7858086 Biopolymer mixture for use in diagnosis, prevention and treatment of acute myeloid leukemia |
| 12/28/2010 | US7858085 Reducing blood glucose level in a non-obese or obese human afflicted with Type 2 diabetes by administering purified human placental alkaline phosphatase |
| 12/28/2010 | US7858084 Administering inactive renalase protein to individuals with lower renalase levels; can be used to provide them with an adequate pool of the protein that can be activated by the body as needed; for individuals needing an immediate reduction of catecholamine levels |
| 12/28/2010 | US7858082 providing a bulk of monomeric protein in a buffer solution and adding an excipient selected from bacteriostatic agents, surfactants, isotonicity agents, amino acids, antioxidants and combinations thereof; refereably the monomeric protein is IFN-beta |
| 12/28/2010 | US7858081 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69 |
| 12/28/2010 | US7858079 biocompatible mixtures of polyethylene glycols and biodegrable polymers functionalized with biotin and avidin or streptavidin, used as bioadhesives |
| 12/28/2010 | US7858070 fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications |
| 12/28/2010 | US7858009 Synthetic leather and method for producing the same |
| 12/23/2010 | WO2010148413A2 Protease variants |
| 12/23/2010 | WO2010148253A2 Formulations for lysosomal enzymes |
| 12/23/2010 | WO2010148234A1 Sap variants and their use |
| 12/23/2010 | WO2010148079A1 Antimicrobial and antibiofilm activity of cathelicidins |
| 12/23/2010 | WO2010148010A1 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularih 1 (mtm1) polypeptides |
| 12/23/2010 | WO2010148007A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| 12/23/2010 | WO2010147981A1 Safe desmopressin administration |
| 12/23/2010 | WO2010147971A2 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 12/23/2010 | WO2010147666A1 Compounds useful as carbonic anhydrase modulators and uses thereof |
| 12/23/2010 | WO2010147547A1 Novel peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation |
| 12/23/2010 | WO2010147484A1 Compositions and methods for treatment of multiple sclerosis |
| 12/23/2010 | WO2010147145A1 Anti-gram-negative bacteria agent |
| 12/23/2010 | WO2010147117A1 Peptide and use thereof |
| 12/23/2010 | WO2010147109A1 Angiogenesis inducer comprising genetically modified gelatin and basic fibroblast growth factor |
| 12/23/2010 | WO2010146606A1 Nanodispersion of a drug and process for its preparation |
| 12/23/2010 | WO2010146578A2 Peptide therapy for increasing platelet levels |
| 12/23/2010 | WO2010146536A1 Suspension of particles with drug |
| 12/23/2010 | WO2010146150A1 Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders |
| 12/23/2010 | WO2010146067A1 Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containing the same |
| 12/23/2010 | WO2010146062A2 Novel anti-helminthic therapies |
| 12/23/2010 | WO2010146055A1 Antagonists of beta-catenin for preventing and/or treating neurodegenerative disorders |
| 12/23/2010 | WO2010145376A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof |
| 12/23/2010 | WO2010145125A1 Highly purified human menopausal gonadotropins, method for preparing and uses thereof |
| 12/23/2010 | WO2010144968A1 Casein derived protease inhibitory peptides |
| 12/23/2010 | WO2010144946A1 Method of determining response to treatment with immunomodulatory composition |
| 12/23/2010 | WO2010126528A9 Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination |
| 12/23/2010 | WO2010123946A3 Silk fibroin hydrogels and uses thereof |
| 12/23/2010 | WO2010122385A8 Fast-acting insulin formulation |
| 12/23/2010 | WO2010105160A3 Method of treating hematological malignancies and hematological neoplasms |
| 12/23/2010 | WO2010104577A3 Methods and kits for treating joints and soft tissues |